AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 13 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,400,000 | +2.9% | 5,100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,247,000 | -60.4% | 5,100,000 | -58.0% | 0.00% | -50.0% |
| Q1 2017 | $13,236,000 | -60.5% | 12,150,000 | -48.8% | 0.00% | -50.0% |
| Q4 2016 | $33,502,000 | +12.4% | 23,750,000 | -10.4% | 0.00% | 0.0% |
| Q3 2016 | $29,796,000 | +35.1% | 26,500,000 | +32.5% | 0.00% | +33.3% |
| Q2 2016 | $22,050,000 | – | 20,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |